UBE2L3 and cervical carcinoma: Among the candidate target genes commonly modulated by the three HP1 isoforms (Supplementary Table S1), UBE2L3 is known to be involved in proteasomal degradation of p53 during cervical cancer progression, interacting with E6AP to form ubiquitination machinery (Fig. 4a) [34, 35].